Gilead Sciences Inc (GILD)
79.58
-0.42 (-0.52%)
USD |
NASDAQ |
Mar 27, 16:00
80.10
+0.52 (+0.65%)
Pre-Market: 08:54
Gilead Sciences Market Cap: 99.24B for March 27, 2023
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| March 27, 2023 | 99.24B |
| March 24, 2023 | 99.77B |
| March 23, 2023 | 98.22B |
| March 22, 2023 | 97.04B |
| March 21, 2023 | 98.70B |
| March 20, 2023 | 99.09B |
| March 17, 2023 | 96.41B |
| March 16, 2023 | 99.58B |
| March 15, 2023 | 99.33B |
| March 14, 2023 | 99.48B |
| March 13, 2023 | 99.16B |
| March 10, 2023 | 99.14B |
| March 09, 2023 | 98.46B |
| March 08, 2023 | 100.02B |
| March 07, 2023 | 100.12B |
| March 06, 2023 | 101.15B |
| March 03, 2023 | 101.10B |
| March 02, 2023 | 99.29B |
| March 01, 2023 | 99.26B |
| February 28, 2023 | 100.43B |
| February 27, 2023 | 100.88B |
| February 24, 2023 | 100.59B |
| February 23, 2023 | 102.94B |
| February 22, 2023 | 104.13B |
| February 21, 2023 | 105.55B |
| Date | Value |
|---|---|
| February 17, 2023 | 105.70B |
| February 16, 2023 | 103.99B |
| February 15, 2023 | 106.06B |
| February 14, 2023 | 106.84B |
| February 13, 2023 | 109.10B |
| February 10, 2023 | 108.11B |
| February 09, 2023 | 106.66B |
| February 08, 2023 | 106.83B |
| February 07, 2023 | 107.30B |
| February 06, 2023 | 107.69B |
| February 03, 2023 | 105.37B |
| February 02, 2023 | 101.49B |
| February 01, 2023 | 104.75B |
| January 31, 2023 | 104.67B |
| January 30, 2023 | 103.94B |
| January 27, 2023 | 104.41B |
| January 26, 2023 | 104.27B |
| January 25, 2023 | 104.84B |
| January 24, 2023 | 104.77B |
| January 23, 2023 | 103.79B |
| January 20, 2023 | 103.51B |
| January 19, 2023 | 104.27B |
| January 18, 2023 | 104.42B |
| January 17, 2023 | 106.51B |
| January 13, 2023 | 107.58B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
71.01B
Minimum
Dec 30 2020
112.22B
Maximum
Dec 08 2022
86.90B
Average
84.87B
Median
Market Cap Benchmarks
| Jounce Therapeutics Inc | 95.42M |
| Johnson & Johnson | 399.24B |
| Pfizer Inc | 226.00B |
| AbbVie Inc | 278.75B |
| Eli Lilly and Co | 318.66B |
Market Cap Related Metrics
| PE Ratio | 21.80 |
| PS Ratio | 3.681 |
| Price to Book Value | 4.672 |
| Price to Free Cash Flow | 12.04 |
| Price | 79.58 |
| Earnings Yield | 4.59% |
| Operating PE Ratio | 9.158 |
| Normalized PE Ratio | 13.43 |